Trials / Active Not Recruiting
Active Not RecruitingNCT05551052
CRC Detection Reliable Assessment With Blood
Prospective, Multi-center Observational Study for the Clinical Validation of the Next Generation Test for Blood-based Screening of Colorectal Cancer
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 196 (actual)
- Sponsor
- New Day Diagnostics · Network
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
The CRC DRAW study will assess the sensitivity and specificity of the blood-based, Next-Gen CRC Screening Test for the detection of CRC.
Detailed description
The CRC DRAW study is a prospective, multi-center, observational study to validate the Next-Gen CRC Screening test for the detection of CRC. The study will collect blood samples from average-risk participants scheduled for screening colonoscopies.
Conditions
- Colorectal Cancer
- Adenomas Colon
- Colon Cancer
- Rectal Cancer
- Colon Neoplasm
- Colon Lesion
- Colon Disease
- Colon Polyp
- Polyps
- Adenoma
- Rectal Diseases
- Rectal Polyp
- Gastrointestinal Neoplasms
- Intestinal Neoplasms
- Colonic Diseases, Functional
- Intestinal Disease
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Next-Gen CRC Screening Test | The Next-Gen CRC Screening Test is a blood-based screening test for detection of CRC. |
Timeline
- Start date
- 2022-09-08
- Primary completion
- 2027-10-31
- Completion
- 2027-12-31
- First posted
- 2022-09-22
- Last updated
- 2025-05-29
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05551052. Inclusion in this directory is not an endorsement.